Evidence of NI-0101 pharmacological activity, an anti-TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS
出版年份 2016 全文链接
标题
Evidence of NI-0101 pharmacological activity, an anti-TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS
作者
关键词
-
出版物
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 101, Issue 2, Pages 200-208
出版商
Wiley
发表日期
2016-10-13
DOI
10.1002/cpt.522
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutic Options After Treatment Failure in Rheumatoid Arthritis or Spondyloarthritides
- (2014) Marcello Govoni et al. ADVANCES IN THERAPY
- A randomized phase 1 pharmacokinetic trial comparing the potential biosimilar PF-05280014 with trastuzumab in healthy volunteers (REFLECTIONS B327-01)
- (2014) Donghua Yin et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody
- (2013) M Reilly et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cytoplasmic LPS Activates Caspase-11: Implications in TLR4-Independent Endotoxic Shock
- (2013) J. A. Hagar et al. SCIENCE
- Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4
- (2013) N. Kayagaki et al. SCIENCE
- Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor- , in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study
- (2011) G. R. Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of Care
- (2011) Jeffrey R. Curtis et al. CLINICAL THERAPEUTICS
- Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies
- (2011) Amisha Barochia et al. Expert Opinion on Drug Metabolism & Toxicology
- Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcγ receptor
- (2010) Jeremy Sokolove et al. ARTHRITIS AND RHEUMATISM
- A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*
- (2010) Todd W. Rice et al. CRITICAL CARE MEDICINE
- Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes
- (2010) Geoff Hale et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The Inhibitory Fc IIb Receptor Dampens TLR4-Mediated Immune Responses and Is Selectively Up-regulated on Dendritic Cells from Rheumatoid Arthritis Patients with Quiescent Disease
- (2009) M. H. Wenink et al. JOURNAL OF IMMUNOLOGY
- Rheumatoid arthritis
- (2009) Lars Klareskog et al. LANCET
- Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
- (2009) L. A. J. O'Neill et al. PHARMACOLOGICAL REVIEWS
- Induction of macrophage secretion of tumor necrosis factor α through Fcγ receptor IIa engagement by rheumatoid arthritis–specific autoantibodies to citrullinated proteins complexed with fibrinogen
- (2008) Cyril Clavel et al. ARTHRITIS AND RHEUMATISM
- Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis
- (2008) Xiaoyan Zhao et al. ARTHRITIS RESEARCH & THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started